GEIST:UPC Searchengine

ORD_43914/2024

Amgen Inc. v. Sanofi Winthrop Industrie S.A., Sanofi-Aventis Deutschland GmbH, Regeneron Pharmaceuticals Inc., Sanofi-Aventis Groupe S.A.

Datum
2024-07-29
Kammer
Munich (DE) Local Division
Verfahrensart
Generic Order
Sprache
EN

Metadaten

Fall-IDORD_43914-2024-c06647198591
Aktenzeichen
RegisterzeichenORD_43914/2024
EntscheidungsreferenzORD_43914/2024
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 3

Local Division Munich UPC_CFI_14/2023 Order in the proceedings before the Court of First Instance of the Unified Patent Court relating to European Patent 3 666 797 delivered on 29/07/2024 Date of receipt of Statement of claim : 01/06/2023 CLAIMANT 1) Amgen Inc. One Amgen Center Drive, Mail-Stop 28-2-C - 91320-1799 - Thousand Oaks - US Represented by Johannes Heselberger DEFENDANTS 1) Sanofi-Aventis Deutschland GmbH Industriepark Höchst, Brüningstraße 50 - 65926 - Frankfurt am Main - DE Represented by Niels Hölder 2) Sanofi-Aventis Groupe S.A. 54 rue La Boétie - 75008 - Paris - FR Represented by Niels Hölder UPC_CFI_14/2023 2 3) Sanofi Winthrop Industrie S.A. 82 avenue Raspail - 94250 - Gentilly - FR Represented by Niels Hölder 4) Regeneron Pharmaceuticals Inc. 81 Columbia Turnpike - 12144  ...